Increasing Clinical Trial Enrollment: A Semi-Automated Patient Centered Approach
Increasing Clinical Trial Enrollment: A Semi-Automated Patient Centered Approach
批准号:
7770648
负责人:
Imre Solti
金额:
$8.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2010-09-29
关键词:
AdultAgeAlgorithmsApplications GrantsArtsBiomedical ResearchCancer PatientCharacteristicsClinicalClinical ResearchClinical TrialsClinical trial protocol documentCodeCommitComplementComputer softwareComputerized Medical RecordDecision MakingDevelopmentElderlyElementsEligibility DeterminationEnrollmentEnsureEquationEvaluationFacultyFoundationsFutureGoalsGoldGrantHandIn VitroInformaticsJavaKnowledgeLaboratoriesLinguisticsMalignant NeoplasmsMapsMedical RecordsMedicineMethodsMinorityModificationNatural Language ProcessingNewly DiagnosedObservational StudyPatientsPerformancePharmaceutical PreparationsPhysiciansProcessProtocols documentationPublic Health InformaticsPublishingRecommendationRecordsRecruitment ActivityResearchResearch DesignRoleScreening for cancerScreening procedureSpecialistSurgeonTextTrainingUnified Medical Language SystemUnited States National Library of MedicineWorkbasecancer careempoweredethnic minority populationinformation organizationnovelolder patientpatient orientedprogramsprospectiveresearch studysoftware developmentsuccesstool
中文摘要
描述(由申请人提供):
这项研究的长期目标是通过基于自然语言处理(NLP)的半自动、交互式和以患者为中心的信息学应用程序来增加美国患者的临床试验登记人数。研究设计为前瞻性观察性研究。范围仅限于癌症患者。这个项目有三个具体目标。第一个目标是确定电子病历(EMR)临床笔记和临床试验公告的免费文本之间重叠的概念。PI将使用这些概念来开发映射框架,将试验公告文本中的概念与医疗记录中的临床笔记中的概念联系起来。当他得到映射帧时,他将为应用程序构建NLP模块。在软件开发工作中,他将利用尽可能多的公开可用的软件组件。他将用UIMA、GATE、MetaMap、Stanford Parser、NegEx算法和其他软件进行实验。PI将围绕国家医学图书馆的统一医学语言系统知识库开发该工具。他将使用Java进行编程。第二个目标是创建一种算法,如果记录中没有或无法访问信息,则自动生成问题,以直接从患者那里请求信息。第三个目标是评估该应用程序的体外和实验室性能。出于绩效评估的目的,PI将招聘癌症护理专家,为研究患者生成合格临床试验的黄金标准清单。他将在授权期结束时公开发布开发的代码。这个K99/R00项目将为未来的R01拨款申请奠定基础。PI致力于成为临床研究信息学领域的教师,拥有生物医学NLP的专业知识。K99/R00拨款的支持将使他能够在计算语言学方面获得大量的正式培训,同时为临床研究信息学领域的知识体系做出贡献。五年的拨款支持将确保他的努力取得成功。这项拟议的工作意义重大,因为令人沮丧的临床试验应收率(全国范围内为2-4%)阻碍了新药的及时开发。此外,研究表明,医生在邀请老年和少数族裔患者参加临床试验时,在统计上存在显著的偏见。拟议的项目与以医生为中心的努力是协同的,但目标是直接向患者提供个性化的、基于EMR的临床试验建议。这项研究的结果将赋予患者权力,提升他们在决策过程中的作用。
英文摘要
DESCRIPTION (provided by applicant):
The long-term objective of this research is to increase the clinical trial enrollment of US patients via a semi- automated, Natural Language Processing (NLP) based, interactive and patient-centered informatics application. The study design is prospective observational study. Scope is limited to cancer patients. There are three specific aims for this project. The first aim is to identify concepts that overlap between the electronic medical record's (EMR) clinical notes and the free text of clinical trial announcements. The PI will use the concepts to develop mapping frames that connect concepts in the text of trial announcements to those found in clinical notes in the medical record. When he has the mapping frames he will build the NLP module for the application. In the software development work he will utilize as many publicly available software components as possible. He will experiment with UIMA, GATE, MetaMap, Stanford Parser, NegEx algorithm and others. The PI will develop the tool around the National Library of Medicine's Unified Medical Language System knowledgebase. He will use Java for programming. The second aim is to create an algorithm that automatically generates questions to request information directly from the patient if the information is not available or accessible in the records. The third aim is to evaluate the in-vitro, laboratory performance of the application. For performance evaluation purposes the PI will recruit cancer care specialists to generate the gold standard lists of eligible clinical trials for study patients. He will publicly release the developed code at the end of the grant period. This K99/R00 project will serve the foundation for future R01 grant applications. The PI is fully committed to become faculty in the Clinical Research Informatics domain with a specialization in biomedical NLP. The support of the K99/R00 grant will enable him to acquire substantial formal training in Computational Linguistics while contributing to the body of knowledge of the Clinical Research Informatics field. The five-year grant support will ensure success in his endeavor. The proposed work is highly significant because the dismal clinical trial accrual rates (2-4 % nationally) hampers timely development of new drugs. In addition, studies show that physicians have statistically significant bias against elderly and minority patients to invite participation in clinical trials. The proposed project is synergistic with physician-centered efforts but the goal is to provide individualized, EMR based clinical trial recommendations directly to the patients. The results of this research will empower the patients and elevate their role in the decision making process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EHR-based patient safety: Automated error detection in neonatal intensive care
-
批准号:8517787
-
项目类别:
-
资助金额:$25.41万
-
财政年份:2012
-
负责人:Imre Solti
-
依托单位:
EHR-based patient safety: Automated error detection in neonatal intensive care
-
批准号:8334934
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2012
-
负责人:Imre Solti
-
依托单位:
Increasing Clinical Trial Enrollment: A Semi-Automated Patient Centered Approach
-
批准号:8331381
-
项目类别:
-
资助金额:$23.89万
-
财政年份:2010
-
负责人:Imre Solti
-
依托单位:
Increasing Clinical Trial Enrollment: A Semi-Automated Patient Centered Approach
-
批准号:8215715
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2010
-
负责人:Imre Solti
-
依托单位:
Increasing Clinical Trial Enrollment: A Semi-Automated Patient Centered Approach
-
批准号:8145098
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:Imre Solti
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: